Japan Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • ID: 4342760
  • Report
  • Region: Japan
  • 122 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline Plc
  • Medtronic plc
  • Nipro Corp
  • MORE
Japan Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

The new report, "Japan Drug Delivery Devices Market Outlook to 2023", provides key market data on the Japan Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the Japan Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Baxter International Inc
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline Plc
  • Medtronic plc
  • Nipro Corp
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Drug Delivery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Drug Delivery Devices Market, Japan
3.1 Drug Delivery Devices Market, Japan, Revenue ($m), 2009-2023
3.2 Drug Delivery Devices Market, Japan, Revenue Mix ($m), 2016
3.3 Drug Delivery Devices Market, Japan, Category Contribution by Revenue ($m), 2016
3.4 Drug Delivery Devices Market, Japan, Category Comparison by Revenue ($m), 2009-2023
3.5 Drug Delivery Devices Market, Japan, Revenue ($m), 2009-2016
3.6 Drug Delivery Devices Market, Japan, Revenue ($m), 2016-2023
3.7 Drug Delivery Devices Market, Japan, Volume (Units), 2009-2023
3.8 Drug Delivery Devices Market, Japan, Volume (Units), 2009-2016
3.9 Drug Delivery Devices Market, Japan, Volume (Units), 2016-2023
3.10 Drug Delivery Devices Market, Japan, Company Share by Revenue ($m), 2016
4 Central Venous Catheters Market, Japan
4.1 Central Venous Catheters Market, Japan, Revenue Mix ($m), 2016
4.2 Central Venous Catheters Market, Japan, Segment Contribution (%), 2016
4.3 Central Venous Catheters Market, India, Revenue ($m), 2009-2016
4.4 Central Venous Catheters Market, India, Revenue ($m), 2016-2023
4.5 Central Venous Catheters Market, India, Volume (Units), 2009-2016
4.6 Central Venous Catheters Market, India, Volume (Units), 2016-2023
4.7 Central Venous Catheters Market, India, Distribution Share by Revenue ($m), 2015-2016
4.8 Central Venous Catheters Market, India, Company Share by Revenue ($m), 2016
5 Infusion Systems Market, Japan
5.1 Infusion Systems Market, Japan, Revenue Mix ($m), 2016
5.2 Infusion Systems Market, Japan, Segment Contribution (%), 2016
5.3 Infusion Systems Market, Japan, Revenue ($m), 2009-2016
5.4 Infusion Systems Market, Japan, Revenue ($m), 2016-2023
5.4.1 Ambulatory Infusion Pumps Market, Japan, Revenue ($m), by Segment, 2009-2016
5.4.2 Syringe Pumps Market, Japan, Revenue ($m), by Segment, 2009-2016
5.4.3 Ambulatory Infusion Pumps Market, Japan, Revenue ($m), by Segment, 2016-2023
5.4.4 Syringe Pumps Market, Japan, Revenue ($m), by Segment, 2016-2023
5.5 Infusion Systems Market, Japan, Volume (Units), 2009-2016
5.6 Infusion Systems Market, Japan, Volume (Units), 2016-2023
5.6.1 Ambulatory Infusion Pumps Market, Japan, Volume (Units), by Segment, 2009-2016
5.6.2 Syringe Pumps Market, Japan, Volume (Units), by Segment, 2009-2016
5.6.3 Ambulatory Infusion Pumps Market, Japan, Volume (Units), by Segment, 2016-2023
5.6.4 Syringe Pumps Market, Japan, Volume (Units), by Segment, 2016-2023
5.7 Infusion Systems Market, Japan, Distribution Share by Revenue ($m), 2015-2016
5.8 Infusion Systems Market, Japan, Company Share by Revenue ($m), 2016
6 Needle Free Injections Market, Japan
6.1 Needle Free Injections Market, Japan, Revenue ($m), 2009-2016
6.2 Needle Free Injections Market, Japan, Revenue ($m), 2016-2023
6.3 Needle Free Injections Market, Japan, Volume (Units), 2009-2016
6.4 Needle Free Injections Market, Japan, Volume (Units), 2016-2023
6.5 Needle Free Injections Market, Japan, Distribution Share by Revenue ($m), 2015-2016
6.6 Needle Free Injections Market, Japan, Company Share by Revenue ($m), 2016
7 Metered Dose Inhaler Devices Market, Japan
7.1 Metered Dose Inhaler Devices Market, Japan, Revenue ($m), 2009-2016
7.2 Metered Dose Inhaler Devices Market, Japan, Revenue ($m), 2016-2023
7.3 Metered Dose Inhaler Devices Market, Japan, Volume (Units), 2009-2016
7.4 Metered Dose Inhaler Devices Market, Japan, Volume (Units), 2016-2023
7.5 Metered Dose Inhaler Devices Market, Japan, Distribution Share by Revenue ($m), 2015-2016
7.6 Metered Dose Inhaler Devices Market, Japan, Company Share by Revenue ($m), 2016
8 Overview of Key Companies in Japan, Drug Delivery Devices Market
8.1 Terumo Corp
8.1.1 Company Overview
8.2 GlaxoSmithKline Plc
8.2.1 Company Overview
8.3 Teleflex Inc
8.3.1 Company Overview
8.4 AstraZeneca Plc
8.4.1 Company Overview
8.5 Boehringer Ingelheim GmbH
8.5.1 Company Overview
8.6 Pfizer Inc
8.6.1 Company Overview
8.7 Merck & Co Inc
8.7.1 Company Overview
8.8 B. Braun Melsungen AG
8.8.1 Company Overview
8.9 Nipro Corp
8.9.1 Company Overview
8.10 Baxter International Inc
8.10.1 Company Overview
8.11 Smiths Medical
8.11.1 Company Overview
8.12 Becton Dickinson and Co
8.12.1 Company Overview
8.13 Hospira Inc
8.13.1 Company Overview
8.14 Fresenius Kabi AG
8.14.1 Company Overview
8.15 Medtronic plc
8.15.1 Company Overview
9 Drug Delivery Devices Market Pipeline Products
10 Financial Deals Landscape
10.1 Asset Transactions
10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
10.2 Equity Offerings
10.2.1 Solasia Pharma to Raise USD31.9 Million in IPO
10.3 Partnerships
10.3.1 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
10.3.2 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
10.3.3 Terumo to Enter into Agreement with Phosphagenics
10.3.4 Pfizer Terminates its Licensing Agreement with pSivida
10.3.5 Bayer Enters into Licensing Agreement with DelSiTech
10.3.6 BioCorRx Enters into Licensing Agreement with Therakine
11 Recent Developments
11.1 Corporate Communications
11.1.1 Jun 16, 2017: Sumitomo Dainippon Pharma announces personnel change
11.1.2 May 08, 2017: Sumitomo Dainippon Pharma announces personnel change
11.1.3 Mar 29, 2017: Sumitomo Dainippon Pharma announces Changes in Executive Officers
11.1.4 Mar 22, 2017: Sumitomo Dainippon Pharma Announces New Chief Executive Officer at Boston Biomedical and Establishment of Global Head of Oncology
11.1.5 Feb 24, 2017: Daiichi Sankyo Appoints New Group Corporate Officers
11.1.6 Feb 24, 2017: Sumitomo Dainippon Pharma announces Changes of Representative Directors and Executive Officers
11.1.7 Feb 09, 2017: Terumo Announces Change of Executive Officers
11.1.8 Jan 31, 2017: Daiichi Sankyo Announces New Chairman and President
11.1.9 Nov 11, 2016: Sumitomo Dainippon Pharma Announces Organizational Realignment and Changes Related to Officers and Other Key Positions
11.1.10 Sep 06, 2016: Daiichi Sankyo Announces New Global Head of Development
11.2 Financial Announcements
11.2.1 Jul 29, 2016: Summary of Consolidated Financial Results For the First Quarter of the Fiscal Year Ending March 31, 2017
11.3 Government and Public Interest
11.3.1 Jul 11, 2017: Daiichi Sankyo Selected for Ninth Consecutive Year as Constituent of FTSE4Good Global Index by FTSE Russell
11.3.2 Jul 03, 2017: 15th Takamine Memorial Daiichi Sankyo Prize Winner Announced
11.4 Legal And Regulatory
11.4.1 Jul 04, 2017: Sumitomo Dainippon Pharma Announces Change in Name of Consolidated Subsidiary Based in U.S.
11.5 Other Significant Developments
11.5.1 Apr 27, 2017: Daiichi Sankyo Announces 15 Billion Yen Manufacturing Investment to Support Acceleration of Antibody Drug Conjugate Portfolio
11.5.2 Jan 26, 2017: Achievement of sales milestone for COPD products
11.5.3 Jan 10, 2017: Daiichi Sankyo Announces Reorganization of Research & Development System
11.5.4 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy
11.6 Product News
11.6.1 Jun 12, 2017: Aptar Pharma Extends its Child-Resistant Nasal Pump Manufacturing Capabilities in North America
11.6.2 Jan 30, 2017: Terumo launches user friendly PLAJEX Luer Lock with Threaded Closure (TC)
11.6.3 Jan 26, 2017: Terumo and Nemera announce compatibility between PLAJEX polymer prefillable syringes and Safe'n'Sound
11.7 Strategy And Business Planning
11.7.1 Feb 24, 2017: Daiichi Sankyo Announces Organizational Restructuring Effective as of April 1, 2017
11.7.2 Feb 15, 2017: Daiichi Sankyo Strengthens Authorized Generic Business through Daiichi Sankyo Espha
11.7.3 Feb 10, 2017: Daiichi Sankyo Announces Further Reorganization of its Research & Development Structure
11.7.4 Jan 31, 2017: Terumo Opens a Branch in Yangon
12 Appendix
12.1 Research Methodology
12.1.1 Coverage
12.1.2 Secondary Research
12.1.3 Primary Research
12.1.4 Company Share Analysis
12.1.5 Distribution Share Analysis
12.1.6 Benchmarking
12.2 Consulting
12.3 Contact
12.4 Disclaimer

List of Tables
Table 1: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, 2009-2023
Table 2: Drug Delivery Devices Market, Japan, Category Contribution by Revenue ($m), 2016
Table 3: Drug Delivery Devices Market, Japan, Category Comparison by Revenue ($m), 2009-2023
Table 4: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
Table 5: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 6: Drug Delivery Devices Market, Japan, Volume (Units), 2009-2023
Table 7: Drug Delivery Devices Market, Japan, Volume (Units), Historic, 2009-2016
Table 8: Drug Delivery Devices Market, Japan, Volume (Units), Forecast, 2016-2023
Table 9: Drug Delivery Devices Market, Japan, Company Share by Revenue ($m), USD Constant, 2016
Table 10: Central Venous Catheters Market, Japan, Segment Contribution (%), 2016
Table 11: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Table 12: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 13: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016
Table 14: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023
Table 15: Central Venous Catheters Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 16: Central Venous Catheters Market, India, Company Share by Revenue ($m), USD Constant, 2016
Table 17: Infusion Systems Market, Japan, Segment Contribution (%), 2016
Table 18: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
Table 19: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 20: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
Table 21: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
Table 22: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 23: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 24: Infusion Systems Market, Japan, Volume (Units), Historic, 2009-2016
Table 25: Infusion Systems Market, Japan, Volume (Units), Forecast, 2016-2023
Table 26: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Historic, 2009-2016
Table 27: Syringe Pumps Market, Japan, Volume (Units), Historic, 2009-2016
Table 28: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Forecast, 2016-2023
Table 29: Syringe Pumps Market, Japan, Volume (Units), Forecast, 2016-2023
Table 30: Infusion Systems Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 31: Infusion Systems Market, Japan, Company Share by Revenue ($m), USD Constant, 2016
Table 32: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
Table 33: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 34: Needle Free Injections Market, Japan, Volume (Units), Historic, 2009-2016
Table 35: Needle Free Injections Market, Japan, Volume (Units), Forecast, 2016-2023
Table 36: Needle Free Injections Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 37: Needle Free Injections Market, Japan, Company Share by Revenue ($m), USD Constant, 2016
Table 38: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
Table 39: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 40: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Historic, 2009-2016
Table 41: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Forecast, 2016-2023
Table 42: Metered Dose Inhaler Devices Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 43: Metered Dose Inhaler Devices Market, Japan, Company Share by Revenue ($m), USD Constant, 2016
Table 44: Drug Delivery Devices Market Pipeline Products
Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
Table 46: Solasia Pharma to Raise USD31.9 Million in IPO
Table 47: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
Table 48: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
Table 49: Terumo to Enter into Agreement with Phosphagenics
Table 50: Pfizer Terminates its Licensing Agreement with pSivida
Table 51: Bayer Enters into Licensing Agreement with DelSiTech
Table 52: BioCorRx Enters into Licensing Agreement with Therakine

List of Figures
Figure 1: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, 2009-2023
Figure 2: Drug Delivery Devices Market, Japan, Revenue Mix ($m), 2016
Figure 3: Drug Delivery Devices Market, Japan, Category Contribution (%), 2016
Figure 4: Drug Delivery Devices Market, Japan, Category Comparison by Revenue ($m), 2009-2023
Figure 5: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 6: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 7: Drug Delivery Devices Market, Japan, Volume (Units), 2009-2023
Figure 8: Drug Delivery Devices Market, Japan, Volume (Units), Historic, 2009-2016
Figure 9: Drug Delivery Devices Market, Japan, Volume (Units), Forecast, 2016-2023
Figure 10: Drug Delivery Devices Market, Japan, Company Share (%) 2016
Figure 11: Central Venous Catheters Market, Japan, Revenue Mix ($m), 2016
Figure 12: Central Venous Catheters Market, Japan, Segment Contribution (%), 2016
Figure 13: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 14: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 15: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016
Figure 16: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023
Figure 17: Central Venous Catheters Market, India, Company Share (%) 2016
Figure 18: Infusion Systems Market, Japan, Revenue Mix ($m), 2016
Figure 19: Infusion Systems Market, Japan, Segment Contribution (%), 2016
Figure 20: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 21: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 22: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 23: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 24: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 25: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 26: Infusion Systems Market, Japan, Volume (Units), Historic, 2009-2016
Figure 27: Infusion Systems Market, Japan, Volume (Units), Forecast, 2016-2023
Figure 28: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Historic, 2009-2016
Figure 29: Syringe Pumps Market, Japan, Volume (Units), Historic, 2009-2016
Figure 30: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Forecast, 2016-2023
Figure 31: Syringe Pumps Market, Japan, Volume (Units), Forecast, 2016-2023
Figure 32: Infusion Systems Market, Japan, Company Share (%) 2016
Figure 33: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 34: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 35: Needle Free Injections Market, Japan, Volume (Units), Historic, 2009-2016
Figure 36: Needle Free Injections Market, Japan, Volume (Units), Forecast, 2016-2023
Figure 37: Needle Free Injections Market, Japan, Company Share (%) 2016
Figure 38: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 39: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 40: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Historic, 2009-2016
Figure 41: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Forecast, 2016-2023
Figure 42: Metered Dose Inhaler Devices Market, Japan, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Terumo Corp
  • GlaxoSmithKline Plc
  • Teleflex Inc
  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • Pfizer Inc
  • Merck & Co Inc
  • B. Braun Melsungen AG
  • Nipro Corp
  • Baxter International Inc
  • Smiths Medical
  • Becton Dickinson and Co
  • Hospira Inc
  • Fresenius Kabi AG
  • Medtronic plc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll